Desentrañar las complejidades de las redes de interacción génica del TNBC hacia mejores terapias
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.El cáncer de mama triple negativo (TNBC) es agresivo. El análisis de la red identificó a EP300 como una proteína clave, lo que condujo al descubrimiento de la tirbanibulina como un posible candidato a fármaco para la reutilización contra el TNBC.
Área De La Ciencia
- En el campo de la oncología
- La bioinformática
- Biología computacional
Sus Antecedentes
- El cáncer de mama triple negativo (TNBC) es un subtipo agresivo con terapias dirigidas limitadas.
- El análisis en red de las interacciones proteína-proteína (IPP) puede identificar proteínas reguladoras clave en el cáncer.
Objetivo Del Estudio
- Identificar las proteínas del núcleo en TNBC utilizando el análisis de la red PPI.
- Descubrir posibles fármacos candidatos para EP300, una proteína clave en TNBC, a través de la reutilización de fármacos.
Principales Métodos
- Construido una red PPI de 1413 genes desregulados en TNBC.
- Las proteínas del eje identificadas incluyen TP53, SRC, EP300, AKT1, HSP90AA1, MAPK3, EGFR y SMAD3.
- Utilizó acoplamiento molecular, MM-GBSA y rescoring basado en ML para examinar los compuestos aprobados por la FDA contra EP300, identificando la tirbanibulina (DB06137).
Principales Resultados
- La red PPI reveló interacciones significativas entre los genes centrales.
- Ningún medicamento aprobado por la FDA se dirige directamente a la proteína EP300.
- La tirbanibulina (DB06137) demostró una fuerte afinidad de unión y estabilidad estructural con EP300, lo que sugiere un potencial terapéutico.
Conclusiones
- La tirbanibulina es un prometedor candidato a fármaco reutilizado para dirigirse a EP300 en TNBC.
- Se requiere una validación experimental adicional para explorar la eficacia y el mecanismo de la tirbanibulina contra el EP300.
- Este estudio pone de relieve el potencial del análisis de redes y la reutilización de fármacos en el avance de las terapias para el CNT.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor tyrosine kinases:
Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...